Stocksigma LogoStocksigma Logo

Samir Ramakant Dave Acquires 5.66% Stake in Chandra Bhagat Pharma

Samir Ramakant Dave acquired 8,00,000 convertible warrants in Chandra Bhagat Pharma Limited via a preferential issue allotted on 22nd Oct'26

Samir Ramakant Dave Acquires 5.66% Stake in Chandra Bhagat Pharma

Chandra Bhagat Pharma Ltd 路 Acquisition/ Disposal of Shares 路 27 Oct 2026, 4:27 pm

Samir Ramakant Dave Acquires 5.66% Stake in Chandra Bhagat Pharma Samir Ramakant Dave acquired 8,00,000 convertible warrants in Chandra Bhagat Pharma Limited via a preferential issue allotted on 22nd Oct'26. The acquisition represents 5.66% of the company's total diluted share and voting capital post-conversion. Prior to this allotment, the acquirer held nil shares. Following the preferential issue and assuming full warrant conversion, Chandra Bhagat Pharma's total diluted equity base expands from 75,45,056 shares to 1,41,45,056 equity shares of face value Rs. 10 each.

Original exchange filing (PDF)

More announcements from Chandra Bhagat Pharma Ltd

All Chandra Bhagat Pharma Ltd announcements